These dysregulated non-coding RNAs are highly stable in the circulatory system and not only serve as liquid biopsy markers (86), but also offer a new strategy for the early detection and prevention of breast cancer through the Cx43-mRNA-circRNAs-miRNAs regulatory axis (81). This evidence concerns the gene GJA1 and breast carcinoma.